Get access

Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: Implications for screening

Authors

  • Kathryn J. Rowland MD, MPHS,

    1. Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
    Search for more papers by this author
  • Rebecca D. Chernock MD,

    1. Department of Pathology, Washington University in St. Louis School of Medicine, St. Louis, Missouri
    Search for more papers by this author
  • Jeffrey F. Moley MD

    Corresponding author
    1. Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, Missouri
    • Correpondence to: Jeffrey F. Moley, MD, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8109, St. Louis, MO 63110. Fax: +1-314-747-1310. E-mail: moleyj@wudosis.wustl.edu

    Search for more papers by this author

  • Conflict of interest: none.

Abstract

Childhood pheochromocytoma in the setting of multiple endocrine neoplasia type 2 (MEN2) remains rare and has not been reported under the age of 12. We present an 8-year-old female with known MEN 2A, C634Y RET mutation, diagnosed with a 6 cm pheochromocytoma requiring laparoscopic adrenalectomy. Given this patient's age at diagnosis, screening guidelines should recommend annual screening beginning at age 8 for patients with MEN 2B or MEN 2A codons 630 or 634 RET mutations. J. Surg. Oncol. 2013 108:203–206. © 2013 Wiley Periodicals, Inc.

Ancillary